Turner Jonathan, Muraoka Alyssa, Bedenbaugh Michael, Childress Blaine, Pernot Lauren, Wiencek Mark, Peterson Yuri K
College of Medicine, Medical University of South Carolina, Charleston, SC, United States.
College of Pharmacy, Medical University of South Carolina, Charleston, SC, United States.
Front Microbiol. 2022 Mar 24;13:807955. doi: 10.3389/fmicb.2022.807955. eCollection 2022.
Beta-lactam antibiotics remain one of the most commonly prescribed drug classes, but they are limited by their propensity to cause hypersensitivity reactions (e.g., from allergy to anaphylaxis) as well as by the emergence of bacteria with a myriad of resistance mechanisms such as β-lactamases. While development efforts continue to focus on overcoming resistance, there are ongoing concerns regarding cross-contamination of β-lactams during manufacturing and compounding of these drugs. Additionally, there is a need to reduce levels of drugs such as β-lactam antibiotics in waste-water to mitigate the risk of environmental exposure. To help address future development of effective remediation chemistries and processes, it is desired to better understand the structural relationship among the most common β-lactams. This study includes the creation of a class-wide structural ordering of the entire β-lactam series, including both United States Food and Drug Association (US-FDA)-approved drugs and experimental therapies. The result is a structural relational map: the "Lactamome," which positions each substance according to architecture and chemical end-group. We utilized a novel method to compare the structural relationships of β-lactam antibiotics among the radial cladogram and describe the positioning with respect to efficacy, resistance to hydrolysis, reported hypersensitivity, and Woodward height. The resulting classification scheme may help with the development of broad-spectrum treatments that reduce the risk of occupational exposure and negative environmental impacts, assist practitioners with avoiding adverse patient reactions, and help direct future drug research.
β-内酰胺类抗生素仍然是最常用的处方药类别之一,但它们存在局限性,容易引起超敏反应(例如,从过敏到过敏反应),并且会出现具有多种耐药机制的细菌,如β-内酰胺酶。虽然研发工作继续专注于克服耐药性,但在这些药物的生产和配制过程中,人们对β-内酰胺类药物的交叉污染仍存在担忧。此外,有必要降低废水中β-内酰胺类抗生素等药物的含量,以降低环境暴露风险。为了有助于解决有效修复化学和工艺的未来发展问题,需要更好地了解最常见的β-内酰胺类药物之间的结构关系。本研究包括对整个β-内酰胺系列进行全类别结构排序,包括美国食品药品监督管理局(US-FDA)批准的药物和实验性疗法。结果是一个结构关系图:“内酰胺组”,它根据结构和化学端基对每种物质进行定位。我们采用了一种新颖的方法来比较放射状分支图中β-内酰胺类抗生素的结构关系,并描述其在疗效、抗水解性、报告的超敏反应和伍德沃德高度方面的定位。由此产生的分类方案可能有助于开发降低职业暴露风险和负面环境影响的广谱治疗方法,帮助从业者避免患者出现不良反应,并指导未来的药物研究。